Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.
Press releases published on May 7, 2025
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …
Century Aluminum Company Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data) Q1 2025 Q4 2024 Aluminum shipments ( …
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
GlobeNewswire
·
May 7, 2025
Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …
MercadoLibre, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Montevideo, May 07, 2025 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) today reported financial results for the first quarter ended March 31, 2025, in a Letter to Shareholders, which is now posted to the company’s …
Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
GlobeNewswire
·
May 7, 2025
NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …
Bessor Announces Changes to the Board
GlobeNewswire
·
May 7, 2025
Vancouver, BC, May 07, 2025 (GLOBE NEWSWIRE) -- Bessor Minerals Inc. (TSXV:BST) ("Bessor" or the “Corporation”) announces Mr. Kieran Downes has resigned as a director of the Corporation. Mr. Downes resigned in order to pursue personal interests unrelated …
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Ripple Price Prediction: Analysts Announce Bullish $7–$10 XRP Projection for Summer — StratoVM Surges 2,939% Amid Market Optimism
GlobeNewswire
·
May 7, 2025
ROAD TOWN, British Virgin Islands, May 07, 2025 (GLOBE NEWSWIRE) -- XRP is making headlines once again as CME Group gears up to launch XRP futures on May 19, signaling a potential surge in institutional interest. Combined with improving regulatory clarity …
AWARD-WINNING FOOD TOUR COMPANY, FLAVORS FOOD TOURS, CELEBRATES ONE YEAR IN SAVANNAH
GlobeNewswire
·
May 7, 2025
SAVANNAH, GA, May 07, 2025 (GLOBE NEWSWIRE) -- Award-winning food tour company, Flavors Food Tours, is celebrating one year since launching its distinctive ‘progressive dining with a difference’ historic cultural food tours in Savannah, Georgia. Business …
Bitget Wallet Unveils Alpha, A Mobile Hub for Early Signals and Trading
GlobeNewswire
·
May 7, 2025
SAN SALVADOR, El Salvador, May 07, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, a leading non-custodial Web3 wallet, has officially launched Bitget Wallet Alpha, a mobile-native discovery engine that enables users to capture trading opportunities with speed, …
Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease
GlobeNewswire
·
May 7, 2025
In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as a novel target in lysosomal storage diseases Amsterdam, the Netherlands, May 07, 2025 – Scenic Biotech, a pioneer in the field of modifier …
Plantro Ltd. Releases Questions for Information Services Corporation’s 2025 First Quarter Earnings Call
GlobeNewswire
·
May 7, 2025
BRIDGETOWN, Barbados, May 07, 2025 (GLOBE NEWSWIRE) -- Plantro Ltd. (“Plantro”) a shareholder of Information Services Corporation (TSX: ISC) (“ISC” or the “Company”) today released questions it hopes ISC management will address to investors and the news …
Lithium Argentina Publishes 2024 Sustainability Report
GlobeNewswire
·
May 7, 2025
ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG. (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) announces the release of its 2024 Sustainability Report, “Lithium With Purpose” (the “Report”). The Report highlights the …
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
May 7, 2025
Enrollment completed for the 6-week interim analysis with 24 of the 36 planned patients now enrolled Company on track to report interim biomarker data from the first 12 patients imminently Completion of patient enrollment and topline results expected Q3 …
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
GlobeNewswire
·
May 7, 2025
BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1- …
Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline
GlobeNewswire
·
May 7, 2025
VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small molecule platform targeting the intersection of metabolism, immunity, and …
Alkeus Pharmaceuticals Presents Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
GlobeNewswire
·
May 7, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced additional data from its Phase 2 clinical study ( …
Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
GlobeNewswire
·
May 7, 2025
Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patents Patent estate covering atrioventricular interval modulation (“AVIM”) therapy now …
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights
GlobeNewswire
·
May 7, 2025
Clene preparing for upcoming meeting in the second quarter with the U.S. Food and Drug Administration (FDA) to reach agreement on its statistical analysis plan (SAP) regarding analysis of neurofilament light chain (NfL) biomarker data Clene collecting NfL …